n exploratory trial of a WT1-W10 immunotherapy against pancreatic cancer in combination with the standard S1 chemotherapy.

Trial Profile

n exploratory trial of a WT1-W10 immunotherapy against pancreatic cancer in combination with the standard S1 chemotherapy.

Suspended
Phase of Trial: Phase I

Latest Information Update: 10 Feb 2017

At a glance

  • Drugs WT1-W10 peptide vaccine (Primary)
  • Indications Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top